Alex Fava

L'hospitalet De Llobregat, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Cancer risks in people on dialysis and kidney transplant recipients: a Catalan cohort study, 2003-21.

Cancer risks in people on dialysis and kidney transplant recipients: a Catalan cohort study, 2003-21.

Journal: Clinical kidney journal

Published: January 07, 2025

Guiding the starting dose of the once-daily formulation of tacrolimus in "de novo" adult renal transplant patients: a population approach.

Guiding the starting dose of the once-daily formulation of tacrolimus in "de novo" adult renal transplant patients: a population approach.

Journal: Frontiers in pharmacology

Published: June 28, 2024

Antifungal prophylaxis with nebulized amphotericin-B in solid-organ transplant recipients with severe COVID-19: a retrospective observational study.

Antifungal prophylaxis with nebulized amphotericin-B in solid-organ transplant recipients with severe COVID-19: a retrospective observational study.

Journal: Frontiers in cellular and infection microbiology

Published: February 13, 2023

A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction.

A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction.

Journal: Kidney international

Published: January 18, 2023

Tacrolimus CYP3A Single-Nucleotide Polymorphisms and Preformed T- and B-Cell Alloimmune Memory Improve Current Pretransplant Rejection-Risk Stratification in Kidney Transplantation.

Tacrolimus CYP3A Single-Nucleotide Polymorphisms and Preformed T- and B-Cell Alloimmune Memory Improve Current Pretransplant Rejection-Risk Stratification in Kidney Transplantation.

Journal: Frontiers in immunology

Published: February 04, 2022

Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients. Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentration-dose ratio.

Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients. Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentration-dose ratio.

Journal: Nefrologia

Published: February 01, 2022

Acute Kidney Injury Following Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma in a Kidney Transplant Recipient.

Acute Kidney Injury Following Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma in a Kidney Transplant Recipient.

Journal: Kidney medicine

Published: August 17, 2021

CMV-Specific Cell-Mediated Immunity Predicts a High Level of CMV Replication After Prophylaxis Withdrawal in Lung Transplant Recipients.

CMV-Specific Cell-Mediated Immunity Predicts a High Level of CMV Replication After Prophylaxis Withdrawal in Lung Transplant Recipients.

Journal: The Journal of infectious diseases

Published: September 01, 2020

Novel insights into the pathobiology of humoral alloimmune memory in kidney transplantation.

Novel insights into the pathobiology of humoral alloimmune memory in kidney transplantation.

Journal: Current opinion in organ transplantation

Published: December 10, 2019

Immune-Monitoring Disease Activity in Primary Membranous Nephropathy.

Immune-Monitoring Disease Activity in Primary Membranous Nephropathy.

Journal: Frontiers in medicine

Published: July 10, 2019

Showing 1-10 of 10

Last Updated: 09/26/2026